Kraft Heinz Company is once again under scrutiny over its dividend payout, as BofA Securities has placed the packaged-food giant in a higher-risk category for potential dividend reductions, alongside Conagra Brands, General Mills, and Campbell's. Morgan Stanley also lowered its price target on Kraft Heinz to $22 from $23, maintaining an Underweight rating, signaling expectations of underperformance relative to its coverage universe. The stock has tumbled more than 40% over the past three years, caught in a broader rout of Big Food stocks pressured by cost inflation, competition from private-label brands, tighter consumer spending, and the appetite-suppressing effects of GLP-1 diabetes and weight-loss drugs.
Earnings and Dividend in Focus
Kraft Heinz is set to report first-quarter results on May 6, with shares closing at $21.94—leaving little room for disappointment. The dividend remains a key draw for investors, with the board maintaining a regular quarterly payout of $0.40 per share, last paid on March 27 to holders of record on March 6. At current prices, the yield is a significant component of the stock's appeal.
Turnaround Strategy Underway
The company is executing a turnaround plan. In February, management abandoned a planned split and instead committed approximately $950 million in capital expenditures for 2026, while pivoting to a $600 million investment in marketing, sales, and research to revive consumer demand, according to Reuters. Scrapping the split is expected to reduce 2026 expenses by about $300 million.
Full-Year Results Raise Concerns
Kraft Heinz reported a 3.5% decline in net sales for 2025, with organic net sales down 3.4%. The company recorded a $4.7 billion operating loss after booking $9.3 billion in non-cash impairment charges, though free cash flow improved to $3.7 billion. The 2026 outlook projects organic net sales to decline between 1.5% and 3.5%, with adjusted EPS in the range of $1.98 to $2.10, well below 2025's $2.60.
CEO Acknowledges Pricing Missteps
Chief Executive Steve Cahillane stated that the company's issues are "fixable and within our control" but conceded that aggressive pricing has left consumers "very disappointed." TD Cowen analyst Robert Moskow noted that some investors likely viewed the businesses as "not in strong enough condition" to operate independently. Deutsche Bank's Steve Powers interpreted the pause as a sign of "deeper problems than previously acknowledged."
Industry Headwinds from GLP-1 Drugs
The broader food industry continues to face pressure from GLP-1 drugs, which reduce appetite. In February, Reuters reported that food and beverage companies are adjusting pack sizes, reformulating ingredients, and discontinuing products in response. EY-Parthenon estimates that $12 billion in snack sales could be at risk over the next decade. Kraft Heinz is responding by introducing nutrition-focused products, including PowerMac—a new Kraft Mac & Cheese variant with 17 grams of protein and 6 grams of fiber per serving—as well as "better-for-you" Lunchables and Capri Sun drinks with reduced sugar and added electrolytes.
Outlook and Market Implications
The dividend warning is not yet a cut, but the pressure is mounting. The success of the $600 million marketing push will be critical in stemming market share losses without eroding margins. With input costs rising and consumers trading down, Kraft Heinz faces a delicate balancing act between brand investment, credit health, and maintaining cash payouts. The stock currently trades more like a turnaround play with a yield than a traditional staples stock. Whether that assessment holds will become clearer after the May 6 earnings report.
